相关实验视频
Updated: Jun 27, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
在帕金森病中慢性深脑刺激前后探索心血管自主功能
Ilaria Cani1,2, Giulia Giannini1,2, Pietro Guaraldi2
1Department of Biomedical and NeuroMotor Sciences (DIBINEM), Alma Mater Studiorum-University of Bologna, Bologna, Italy.
Movement disorders clinical practice
|May 3, 2024
概括
脑下深层刺激 (STN-DBS) 在帕金森病 (PD) 中不会改变血压控制. 然而,利沃多巴显著降低血压,STN-DBS降低了利沃多巴诱导的正静性低血压.
科学领域:
- 神经学 神经学
- 心血管生理学心血管生理学
- 神经外科 神经外科
背景情况:
- 帕金森病 (PD) 管理涉及复杂的血压调节.
- 自主功能障碍和勒沃多巴治疗显著影响了PD患者的血压,这些患者接受了脑下大脑深度刺激 (STN-DBS).
研究的目的:
- 研究慢性STN-DBS,莱沃多巴及其组合对帕金森病患者心血管自主功能的影响.
主要方法:
- 心血管反射测试 (CRT) 对20名PD患者进行了STN-DBS手术前和6个月后的心血管反射测试.
- 在没有药物 (med-OFF) 和有药物 (med-ON) 的情况下进行CRT.
主要成果:
- 在医疗关闭状态下,在STN-DBS前后之间没有观察到CRT结果或神经性正静性低血压 (OH) 的显著差异.
- 莱沃多巴的摄入导致在HUTT (头向上倾斜测试) 期间血压下降显著更大,相比于在STN-DBS前和后的med-OFF.
- 列沃多巴诱导的OH发生率从STN-DBS前的25%降低到STN-DBS后的5%在med-ON条件下.
结论:
- 慢性STN-DBS似乎不会影响PD患者的心血管自主反应.
- 列沃多巴显著影响血压,导致低血压效应.
- 通过STN-DBS手术,减少了勒沃多巴诱导的正静性低血压的发生.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537

